Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001179110-18-002291
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-16 17:10:19
Reporting Period:
2018-02-14
Accepted Time:
2018-02-16 17:10:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Allergan Plc AGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536778 William Meury Clonshaugh Business And Technology Park,
Coolock, Co.
Dublin L2 D17 E400
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-02-14 1,957 $51.07 56,944 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-02-14 2,765 $51.07 59,709 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-02-14 1,510 $66.20 61,219 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-02-14 17,381 $66.20 78,600 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 25,079 $157.18 53,521 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 1,200 $157.60 52,321 No 4 S Direct
Ordinary Shares, Par Vaule $0.0001 Disposition 2018-02-14 1,700 $158.78 50,621 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 2,400 $159.82 48,221 No 4 S Direct
Ordinary Shares, Par Vaule $0.0001 Disposition 2018-02-14 1,000 $161.10 47,221 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 4,700 $162.22 42,521 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 7,200 $163.04 35,321 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 2,000 $164.62 33,321 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Disposition 2018-02-14 13,600 $165.16 19,721 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Incentive Stock Option Disposition 2018-02-14 1,957 $0.00 1,957 $51.07
Ordinary Shares Non-Qualified Options to Purchase Common Stock Disposition 2018-02-14 2,765 $0.00 2,765 $51.07
Ordinary Shares Incentive Stock Option Disposition 2018-02-14 1,510 $0.00 1,510 $66.20
Ordinary Shares Non-Qualified Options to Purchase Common Stock Disposition 2018-02-14 17,381 $0.00 17,381 $66.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-07 No 4 M Direct
0 2018-12-07 No 4 M Direct
0 2019-12-06 No 4 M Direct
0 2019-12-06 No 4 M Direct
Footnotes
  1. The total number of shares reported has been reduced by 423 due to prior inadvertent over-reporting of shares beneficially owned by the Reporting Person.
  2. Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.29 to $157.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.30 to $158.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.30 to $159.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.41 to $160.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.59 to $161.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.67 to $162.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.68 to $163.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.04 to $165.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.05 to $165.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  12. The option vested on December 8, 2013.
  13. The option vested in five equal installments on December 8, 2009, 2010, 2011, 2012 and 2013.
  14. The option vested on December 7, 2014.
  15. The option vested in five equal installments on December 7, 2010, 2011, 2012, 2013 and 2014.